How to Treat Stasis Dermatitis

Stasis dermatitis—also known as venous stasis dermatitis or gravitational dermatitis—is a chronic inflammatory skin condition that arises secondary to chronic venous insufficiency. It typically affects the lower legs and ankles, where impaired venous return leads to increased capillary pressure, microvascular leakage, and subsequent tissue hypoxia and inflammation.

Effective management hinges on addressing both the underlying venous pathology and the cutaneous manifestations. First-line therapy centers on improving venous hemodynamics: graduated compression stockings (typically 20–30 mmHg or 30–40 mmHg, depending on severity and tolerance) are essential for reducing edema, enhancing venous return, and preventing disease progression. Patients must be fitted properly and wear them daily during ambulation.

Topical corticosteroids—such as triamcinolone 0.1% or betamethasone valerate 0.1%—are used short-term to control acute inflammation, pruritus, and scaling. Long-term use should be avoided due to risks of skin atrophy and telangiectasia. For patients with concomitant infection—often presenting as worsening erythema, warmth, pain, or purulent exudate—targeted antimicrobial therapy is indicated; oral antibiotics like cephalexin or dicloxacillin are commonly prescribed for cellulitis, while topical mupirocin may suffice for localized impetiginization.

Adjunctive measures include rigorous skin hydration with fragrance-free emollients to restore epidermal barrier function, elevation of the legs above heart level several times daily to reduce hydrostatic pressure, and avoidance of trauma or irritants. In select cases—particularly those with recurrent ulceration or refractory symptoms—referral to a vascular specialist for evaluation of endovenous ablation, sclerotherapy, or surgical intervention may be warranted.

Without consistent, multimodal treatment, stasis dermatitis can progress to lipodermatosclerosis, atrophie blanche, or venous leg ulcers—complications that significantly impair quality of life and increase healthcare burden. Patient education on lifelong compression adherence and early recognition of worsening signs remains a cornerstone of successful long-term outcomes.